Press Releases

Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

Comment(0)

Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr. Falk Pharma, a research-based pharmaceutical […]
Read more

Related Articles
Press Releases

The World’s Most Important Residence and Citizenship Programs in 2026

Asianet Pakistan

LONDON, Feb. 24, 2026 (GLOBE NEWSWIRE) — While European programs continue to set the benchmark globally, the latest rankings in the 2026 edition of Henley & Partners’ Residence and Citizenship Programs report reveal a marked recalibration in the investment migration landscape. Europe’s appeal is increasingly being challenged by dynamic competitors across the Middle East, Asia-Pacific, Latin America, and […]
Press Releases

Bitget and Obside Partner to Launch Live AI Trading Arena for Copy Trading

Asianet Pakistan

Bitget and Obside Partner to Launch Live AI Trading Arena for Copy Trading VICTORIA, Seychelles, March 01, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), today announced a partnership with Obside, bringing the AI Trading Arena to Bitget through copy trading. Developed by Obside, the AI Trading Arena is a live environment where advanced […]
Press Releases

AlphaTON Capital at Consensus Hong Kong: Unveiling the Confidential AI Infrastructure for 1 Billion Users

Asianet Pakistan

CEO Brittany Kaiser, Strategic Advisor Anthony Scaramucci, and Midnight Foundation President Fahmi Syed to Showcase AlphaTON’s First-Mover Position in Privacy-Preserving AI at Scale HONG KONG, Feb. 10, 2026 (GLOBE NEWSWIRE) — AlphaTON Capital Corp. (Nasdaq: ATON), the world’s leading public technology company scaling the Telegram super app for an addressable market of over 1 billion monthly […]